A股異動丨寧德時代(300750.SZ)午後拉昇4.33% 與印尼政府和韓國LG化學達成協議 共建鋰電池工廠
格隆匯9月17日丨寧德時代(300750.SZ)午後拉昇4.33%,報200.59元,總市值4672.7億元。據外媒,印尼海事和投資事務協調部長盧哈特•潘傑蓋丹表示,印尼政府已經與韓國LG化學和寧德時代達成了在該國建設鋰電池工廠的協議,預計將於2024年開始生產鋰電池。另外,盧哈特稱,該項投資將擴展到鋰電池下游產業。印尼將發揮其鎳資源優勢,今年早些時候,印尼政府停止了其未加工鎳的出口,以確保該國的鎳原料供應。該項投資規模尚未公佈。寧德時代本週還投資近4400萬元入股加拿大鋰業公司,協助開發阿根廷鋰礦。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.